AAAAAA
Results:
1-9
|
Results: 9
Authors:
Scholze, J
Sharma, AM
Citation: J. Scholze et Am. Sharma, Treatment of hypertension in obesity, HERZ, 26(3), 2001, pp. 209-221
Authors:
Klaua, S
Ablassmaier, B
Thier, P
Ohlrich, S
Karnahl, B
Scholze, J
Citation: S. Klaua et al., The CHARMANT study on morbid obesity - Interim results, NIEREN HOCH, 30(5), 2001, pp. 213-216
Authors:
Scholze, J
Middeke, M
Schrader, J
Citation: J. Scholze et al., German heart rate study, NIEREN HOCH, 30(5), 2001, pp. 235-238
Authors:
Sharma, AM
Pischon, T
Engeli, S
Scholze, J
Citation: Am. Sharma et al., Choice of drug treatment for obesity-related hypertension: where is the evidence?, J HYPERTENS, 19(4), 2001, pp. 667-674
Authors:
Dorffel, Y
Franz, S
Pruss, A
Neumann, G
Rohde, W
Burmester, GR
Scholze, J
Citation: Y. Dorffel et al., Preactivated monocytes from hypertensive patients as a factor for atherosclerosis?, ATHEROSCLER, 157(1), 2001, pp. 151-160
Authors:
Scholze, J
Probst, G
Bertsch, K
Citation: J. Scholze et al., Valsartan alone and in combination with hydrochlorothiazide in general practice - Results from two postmarketing surveillance studies involving 54 928 patients with essential hypertension, CLIN DRUG I, 20(1), 2000, pp. 1-7
Authors:
Scholze, J
Bauer, B
Massaro, J
Citation: J. Scholze et al., Antihypertensive profiles with ascending dose combinations of ramipril andfelodipine ER, CLIN EXP HY, 21(8), 1999, pp. 1447-1462
Authors:
Dorffel, Y
Latsch, C
Stuhlmuller, B
Schreiber, S
Scholze, S
Burmester, GR
Scholze, J
Citation: Y. Dorffel et al., Preactivated peripheral blood monocytes in patients with essential hypertension, HYPERTENSIO, 34(1), 1999, pp. 113-117
Authors:
Hansen, A
Feist, E
Hiepe, F
Burmester, GR
Scholze, J
Citation: A. Hansen et al., Diffuse infiltrative lymphocytosis syndrome in a patient with anti-52-kd Ro/SSA and human immunodeficiency virus type 1, ARTH RHEUM, 42(3), 1999, pp. 578-580
Risultati:
1-9
|